Myostatin: a Circulating Biomarker Correlating with Disease in Myotubular Myopathy Mice and Patients

[1]  R. Grange,et al.  AAV-Mediated Gene Transfer Restores a Normal Muscle Transcriptome in a Canine Model of X-Linked Myotubular Myopathy. , 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

[2]  L. Thielemans,et al.  Translational medicine in neuromuscular disorders: from academia to industry , 2019, Disease Models & Mechanisms.

[3]  Jin-hai Tang,et al.  MiR-27a: A Novel Biomarker and Potential Therapeutic Target in Tumors , 2019, Journal of Cancer.

[4]  L. Servais,et al.  X-linked myotubular myopathy , 2019, Neurology.

[5]  Arun K. Ramani,et al.  Tamoxifen therapy in a murine model of myotubular myopathy , 2018, Nature Communications.

[6]  Shuling Guo,et al.  Reducing dynamin 2 (DNM2) rescues DNM2-related dominant centronuclear myopathy , 2018, Proceedings of the National Academy of Sciences.

[7]  L. Servais,et al.  An integrated modelling methodology for estimating the prevalence of centronuclear myopathy , 2018, Neuromuscular Disorders.

[8]  N. Messaddeq,et al.  Single Intramuscular Injection of AAV-shRNA Reduces DNM2 and Prevents Myotubular Myopathy in Mice. , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

[9]  A. Roux,et al.  Amphiphysin (BIN1) negatively regulates dynamin 2 for normal muscle maturation , 2017, The Journal of clinical investigation.

[10]  F. Muntoni,et al.  Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches , 2017, Nature Communications.

[11]  Shuling Guo,et al.  Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice , 2017, Nature Communications.

[12]  Hanns Lochmüller,et al.  Reduced serum myostatin concentrations associated with genetic muscle disease progression , 2017, Journal of Neurology.

[13]  F. Muntoni,et al.  Cellular, biochemical and molecular changes in muscles from patients with X-linked myotubular myopathy due to MTM1 mutations , 2016, Human molecular genetics.

[14]  Richard T. Lee,et al.  Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation. , 2016, Circulation research.

[15]  A. Gomes,et al.  Acute resistance exercise activates rapamycin‐sensitive and ‐insensitive mechanisms that control translational activity and capacity in skeletal muscle , 2016, The Journal of physiology.

[16]  I. Clay,et al.  GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration. , 2015, Cell metabolism.

[17]  G. Ravenscroft,et al.  Pathophysiological concepts in the congenital myopathies: blurring the boundaries, sharpening the focus. , 2015, Brain : a journal of neurology.

[18]  Shelly C. Lu,et al.  Activation of a novel c-Myc-miR27-prohibitin 1 circuitry in cholestatic liver injury inhibits glutathione synthesis in mice. , 2015, Antioxidants & redox signaling.

[19]  E. Malfatti,et al.  Adult-onset autosomal dominant centronuclear myopathy due to BIN1 mutations. , 2014, Brain : a journal of neurology.

[20]  Fujun Liu,et al.  Differential muscle hypertrophy is associated with satellite cell numbers and Akt pathway activation following activin type IIB receptor inhibition in Mtm1 p.R69C mice. , 2014, The American journal of pathology.

[21]  N. Romero,et al.  Reducing dynamin 2 expression rescues X-linked centronuclear myopathy. , 2014, The Journal of clinical investigation.

[22]  Jocelyn Laporte,et al.  Mutation spectrum in the large GTPase dynamin 2, and genotype–phenotype correlation in autosomal dominant centronuclear myopathy , 2012, Human mutation.

[23]  E. Olson,et al.  Mice lacking microRNA 133a develop dynamin 2–dependent centronuclear myopathy. , 2011, The Journal of clinical investigation.

[24]  I. Nishino,et al.  Molecular Pathogenesis of Genetic and Inherited Diseases Increased Expression of Wild-Type or a Centronuclear Myopathy Mutant of Dynamin 2 in Skeletal Muscle of Adult Mice Leads to Structural Defects and Muscle Weakness , 2011 .

[25]  A. Buj-Bello,et al.  Molecular Pathogenesis of Genetic and Inherited Diseases Inhibition of Activin Receptor Type IIB Increases Strength and Lifespan in Myotubularin-Deficient Mice , 2011 .

[26]  J. Lainé,et al.  A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice. , 2010, Human molecular genetics.

[27]  Andrea M. Hanson,et al.  CCAAT/enhancer binding protein-delta expression is increased in fast skeletal muscle by food deprivation and regulates myostatin transcription in vitro. , 2010, American journal of physiology. Regulatory, integrative and comparative physiology.

[28]  J. Reecy,et al.  Myostatin genotype regulates muscle-specific miRNA expression in mouse pectoralis muscle , 2010, BMC Research Notes.

[29]  Straub,et al.  RYR1 mutations are a common cause of congenital myopathies with central nuclei , 2010, Annals of neurology.

[30]  A. Siwkowski,et al.  Design, synthesis and evaluation of constrained methoxyethyl (cMOE) and constrained ethyl (cEt) nucleoside analogs. , 2008, Nucleic acids symposium series.

[31]  A. Goldberg,et al.  Identification of a Novel Pool of Extracellular Pro-myostatin in Skeletal Muscle* , 2008, Journal of Biological Chemistry.

[32]  C. Wallgren‐Pettersson,et al.  Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy , 2007, Nature Genetics.

[33]  A. Beggs,et al.  Mutations in dynamin 2 cause dominant centronuclear myopathy , 2005, Nature Genetics.

[34]  V. Ambros,et al.  Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation , 2004, Genome Biology.

[35]  Hala G. Zahreddine,et al.  The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Se-Jin Lee,et al.  Regulation of myostatin activity and muscle growth , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Se-Jin Lee,et al.  Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member , 1997, nature.

[38]  S. Klauck,et al.  A gene mutated in X–linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast , 1996, Nature Genetics.

[39]  D. Allen,et al.  Posttranscriptional mechanisms involving microRNA-27a and b contribute to fast-specific and glucocorticoid-mediated myostatin expression in skeletal muscle. , 2011, American journal of physiology. Cell physiology.

[40]  A. Nakamura,et al.  MicroRNA-206 is highly expressed in newly formed muscle fibers: implications regarding potential for muscle regeneration and maturation in muscular dystrophy. , 2008, Cell structure and function.